Monitoring Patient Glucose Levels: New Advances in software make it easier
...r and calibration readings, and look at a combined model day. Another example of using cutting-edge software applications to facilitate communication with the physicians office is being adopted in Europe. Patients in France are using their cell phones to send their glucose levels and other information to ...Bench-Top Centrifuges--Basic Tools for the Small Lab
...tory Products, Asheville, N.C., produces the Primo model as part of its extensive Sorvall line of centrifug...n one instrument. A similar Primo R (refrigerated) model is also available. Both devices are available with a wide choice of rotors and adapters for tubes fr......ut spares normal tissue, and the need for ananimal model that allows monitoring of tumor growth and metastasiswithout having to kill and dissect the animal. They solved the monitoring problem by modifying two lines ofpancreatic cancer to stably express firefly luciferace enzyme - thebioluminescent agent t...Stanford Researchers Find Brain Pathway of Depression in Rats
...he team carried out the study using a standard rat model ofdepression. Even though the rats do not mimic th...did not equaldepression. In other words, in their model system, the two states appear tofunnel through a common pathway--despite very different cellularmech......s froma study conducted in an accepted in vivo rat model of breastcancer. The study was conducted in collab...rt, the effects of Proellex were evaluatedin a rat model wherein breast tumors are induced via a knowncarcinogenic compound. In the study, the hormone proges......life science companies has embarked on newbusiness model “Drug Discovery and Development SupportServices” (DDDSS) with the onset of Intellectual PropertyRegime in India since January 2005. A focused provider of DDDSS for development of New ChemicalEntities to life sciences companies, Suven&rsq......ltiple areas of atypia andcalcification." The Gail model predicts risk by using age at onsetof menses, age ...e. The current study contributes to Mayo'semerging model that seeks to define every woman's risk moreprecisely and to tailor screening and risk-reduction mea...ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
...s, preservedbone mass and architecture in a murine model of multiple myeloma.Multiple myeloma is a malignan...itedby the encouraging results in this preclinical model of multiplemyeloma as we prepare for a phase 2 clinical trial in multiplemyeloma later this year". ......ed learning impairment in a wellestablished animal model of Alzheimer's Disease. This response wasassociated with SIRT1 dependent deacetylation of PGC1a. Resveratrolalso promoted neuronal survival in cell based models of Alzheimer'sDisease and ALS. The three senior authors of the EMBO article include Sirt......s. Betacell function was measured using a computer model based evaluation.Parameters of beta cell function from this model allowed for theestimation of the insulin secretion rate (ISR) and thecharacterization of the ISR int......preclinical observations in a spinal cordparalysis model of statistically significant improvement in hindli...eclinical animal efficacy studiesin a diabetic rat model (Diabetes, June 1, 2006; 55(6): 1847-1854),SB-509 has proven effective in protecting motor and senso...Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
...oral dosing in anhighly refractory diabetic animal model compared with nosignificant change with vildaglipt...on of the smart inhibitor. In ZDF rats, an animal model that develops overt diabetes,ARI-2243 produced a significant reduction in HbA1c of 2.5% and 2.2%vers......tite andcauses differential weight loss in a mouse model of diet-inducedobesity (DIO). Data presented also indicates that trodusquemineselectively inhibits PTP-1B, an enzyme central to controlling thefunction of both the leptin and insulin pathways. In addition,trodusquemine was shown to reduce the size of...... ofpersistent sleep in a well established clinical model of transientinsomnia in healthy adults. In the multi-center, 369 subject study,NG2-73 was shown to significantly reduce time to onset ofpersistent sleep versus placebo at all doses tested. NG2-73 waswell-tolerated at all doses, with no drug-related s......t significant decreases in food intake in ananimal model made insulin resistant and obese after three months ona 60 percent fat diet. The majority of the weight loss is observedin white adipose tissue, with sparing of skeletal muscle.Furthermore, glucose surge and disposal was found to be improvedsignifica......folio, theCompany applies a balanced risk business model to the developmentof its Anticalin candidates. About the Anticalin(R) technology Anticalins are derived from the lipocalin scaffold, originallydeveloped by Prof. Dr. Arne Skerra, a leading expert in the fieldand Head of the Department of Biological......opoietin hasdemonstrated, in a pre-clinical animal model comparative study,increased durability and biological effect over Amgen Inc.'sAranesp(R), a long-acting erythropoietin with reported sales of$4.1 billion in 2006, out of a total estimated EPO market size of$11.7 billion. Erythropoietin is prescribed ...First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
...tiesand strategic partners are key to our business model and we aredelighted to be part of this dynamic program to discover a newfrontier in medicine. We are actively seeking pharmaceuticalpartnerships to help us accelerate the development and validationprocess of these new and exciting compounds." Alle...... study as well as the previously conductedcachexia model study. QR-443 was formulated with the intention to impact metabolicimbalances and chronic inflammation. Cachexia is an extremelydebilitating and life threatening, wasting syndrome associated withchronic diseases such as cancer, AIDS, chronic renal f...Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
...g sciatic nerve crush. Furthermore, in theSOD1G93A model of familial ALS, TRO19622 treatment improves motorperformance, delays the onset of the clinical disease, and extendssurvival. TRO19622 binds directly to two components of the mitochondrialpermeability transition pore: the voltage-dependent anion cha......validation of our product-based business model.The model is for Geron to provide cell-based therapies asoff-the-shelf products for the treatment of chronic degenerativediseases." Oligodendroglial Progenitors for the Treatment of Spinal CordInjury The properties and functions of GRNOPC1, Geron's lead hESC...... data presented show that 57-57, in anexperimental model of the disease systemic lupus erythematosus(SLE), can replace prednisolone, an anti-inflammatorycorticosteroid widely used in a broad range of differentinflammatory diseases, among them SLE. Several symptoms commonly associated with SLE, such as hem...New Positive Pre-clinical Data for Active Biotech's RA Project I-3D
...ry effect on disease development in anexperimental model for rheumatoid arthritis (RA)", commented SvenAndréasson, President & CEO Active Biotech. An additive inhibitory effect on disease development is achievedwhen I-3D is combined with methotrexate, an anti-proliferative drugwidely used for t...Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and Maintenance vs. Placebo
...tting using a phase-advance,first-night assessment model of transient insomnia. The trialexamined VEC-162 dosed 30 minutes before bedtime at 20, 50 and 100mg versus placebo. "Study patients reported they were falling asleep faster andstaying asleep longer," said Tom Roth, Ph.D., Director of the HenryFord ...... polysomnographic modelof transient insomnia. This model of transient insomnia used bothfirst night adaptation and "phase-advance" to create insomnia inhealthy subjects. Subjects completed questionnaires assessing sleepeffects, sleep quality, and next day functioning. Safety wasmonitored as per usual pract...... improved neuron survival in astandard animal cell model of brain inflammation, researchersreported today in a platform presentation at theBioelectromagnetics Society (BEMS,http://www.bioelectromagnetics.org) Annual Meeting, in Kanazawa,Japan. Inflammation is associated with neuron death that occurs inPark......rate results. The procedure toarrive at a reliable model involves a detailed analysis ofpotential confoundi...r, work regarding theadjustment of the statistical model is ongoing and, thereforeresults of the Phase III clinical trial cannot be derived from theprelimina...Trial Results with Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer
...rsity of Copenhagen, Denmark,explained ‘As a model for patients with cancer, we testedintranasal fentanyl to treat patients suffering pain after dentalsurgery.’ Dr Christrup also stated that ‘The intranasalfentanyl spray used in our study provided tight control of the painmeaning fast ons......r on theresults of FP0011 in a MPTP macaque monkey model of Parkinson'sdisease, by Dr. Jonathan Brotchie, CEO of Atuka Ltd. of Toronto,Canada. In this trial, monkeys that have developed dyskinesia fromthe administration of L-dopa to treat Parkinsonian symptoms fromthe neurotoxin, MPTP, were administered FP......b,sunitinib, and sorafenib) in a highly aggressive model of malignantmelanoma. A summary of these preclinical data can be viewed at:<a target="_blank" href="http://www.genta.com/Genta/InvestorRelation/2006/press_20061109.html">http://www.genta.com/Genta/InvestorRelation/2006/press_20061109.html A...... vs. 27%, respectively). ACox proportional hazards model accounting for the effects of theRecursive Partitioning Analysis (RPA) class was performed, and theeffect of Gliadel treatment on survival was found to approachsignificance (pless than 0.055). Adverse events were similar inpatients treated with or wi......s receivingplacebo (43.3%). Using a Cox regression model to adjust for thefact that patients in the different arms were enrolled in the studyat different times, there was a 27% reduction in the relative riskof cancer recurrence following surgery, compared with placebo(p=0.107). Although the study was not p......vs. 27%, respectively). A Cox proportional hazards model accountingfor the effects of the Recursive Partitioning Analysis (RPA) classwas performed, and the effect of Gliadel treatment on survival wasfound to approach significance (p less than 0.055). Adverse eventswere similar in patients treated with or w......gainst human urothelial carcinoma in a preclinical model About US Oncology Research The US Oncology Research Network is an establishedcommunity-based research operation specializing in all phases ofcancer clinical trials. The research network currently has 528physicians actively enrolling patients, 82 re...Vision Deficit in Retinitis Pigmentosa Mice Corrected with DNA Nanoparticles
...A nanoparticles correctedvision defects in a mouse model of retinitis pigmentosa (RP). Thesefindings were presented at the American Society of Gene Therapymeeting in Seattle, WA. Mutations in genes important in the biologyof vision cause RP, a common genetic form of visual impairmentaffecting nearly 70,000......Preclinical study evaluating a clinically relevant model ofnormal human skin found that Menadione was the o... preclinical study evaluating a clinicallyrelevant model of normal human skin found that Menadione was theonly agent capable of abrogating the cytotoxic effe...Genmab's HuMax-EGFr Shows Broad Potential in Cancer Treatment
...otoxicity (ADCC). Genmab scientists also used the model to test the effects oftyrosine kinase inhibitors (TKI) such as the marketed productsIressa and Tarceva on EGFr-expressing tumor cells. Tumor cellsexpressing various mutated EGFr varied strongly in theirsensitivity to TKI therapy, whereas no differenc...Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference
...inical datashows exciting results in a widely used model of breast cancer. Bytargeting tumor vascularization, Angiolix has the potential tocause tumor regression and prevent recurrence of growth." "On behalf of both companies we are grateful for the opportunityto present data at this year's ASCO Conferenc...Biothera's Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study
...G in combination with Avastin in a xenograft mouse model wherehuman ovarian cancer cells were implanted into the mice. In thetreatment group receiving both Imprime PGG and Avastin, 86% of themice survived 100 days compared with only 43% in the groupreceiving Avastin alone. "The combination of Imprime PGG ...... which represent the most relevantinfluenza animal model for humans, were then challenged with liveH5N1 virus, and all survived. The typical human dose of a seasonalinfluenza vaccine is 15 micrograms. Other pandemic vaccines with noadjuvant have shown only modest levels of immunogenicity in humanswith dose...EntreMed's Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical Models
...on withminimal toxicity in a preclinical xenograft model of humanleukemia. This activity is consistent with tumor regression inducedby ENMD-981693 in preclinical models of human tumors derived fromcolon, leukemia, and breast cancer cell lines. Mark R. Bray, Ph.D., Vice President, Research at EntreMed,comm...Hemispherx Presents Potential Avian Influenza Treatment Breakthrough at Paris Conference
...logy resulting from infection ofestablished animal model non-human primates (macaques) by a highlypathogenic strain of avian flu. As noted in a 2006 Oxford University Clinical Research Unitstudy titled "Fatal outcome of human influenza A (H5N1) isassociated with high viral load and hypercytokinemia," illn...Antidepressant Use May Boost Fracture Risk, From Harvard Women's Health Watch
...d bone loss. Researchers working with an animal model found that depressiontriggers the release of noradrenaline, which interferes withbone-building cells. Moreover, they found that imipramine-a memberof an older class of drugs called tricyclicantidepressants-reversed both depression and depression- ind......incorporated a single-night, polysomnography (PSG) model oftransient insomnia using both first night sleep laboratoryadaptation and "phase-advance" effects. Subjects were dosed in thesleep laboratory 2.5 hours prior to median habitual bedtime."Lights off" and PSG recording started 30 minutes later. Safety ...Sosei Announces Successful Completion of AD 923 Pharmacokinetic Study in the USA
...lopment. It has established a reduced riskbusiness model primarily upon identifying new uses for establisheddrugs and exploiting its unique position within Japanese, Europeanand North American pharmaceutical markets by acquiring compoundsfrom, and bringing compounds into, Japan. For further information ab...... data. A Coxproportional-hazards model, which is a model used to determine theunderlying rate of risk, was ...el), and CDAI atweek 4. A Cox proportional-hazards model showed HUMIRA wasassociated with a significantly lower risk of hospitalization(hazard ratio=0.31, p ......r cancer,was highly effective in a rigorous animal model of breast cancerand that the drug inhibits signali...studies of RTA 402 in the highlyrigorous 4T1 mouse model of breast cancer. Few other agents haveshown any effect in this animal model, in which tumors grow v...Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in Preclinical Studies
... preclinical studies in normal mice and in a mouse model ofmuscular dystrophy. These studies show a substan...e further as treatmentcontinues. In the mdx murine model of muscular dystrophy, treatedanimals showed increases in muscle mass which translated intosignifica...SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193
...Lassa fever infections, and SIGA expects that this model isone of the two animal models that will be required to fulfill theU.S. Food and Drug Administration's "Animal Efficacy Rule." "This is a tremendous milestone for our research group," saidDr. Dennis E. Hruby, SIGA's Chief Scientific Officer. "This...Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
...m preclinical studies in normal mice and in amouse model of muscular dystrophy. These studies show a substa...e further as treatmentcontinues. In the mdx murine model of muscular dystrophy, treatedanimals showed increases in muscle mass which translated intosignifica...Alnylam Reports Results of Human Experimental Infection Model with Respiratory Syncytial Virus
...nd quarterof this year. The experimental infection model was designed to evaluate viralinfectivity of RSV a...flu and the common cold, and we believe thatsuch a model is a significant advance for the development of novelanti-RSV therapies. Importantly, with an experi......NeuralTherapy and Repair. The data generated, in a model of spinal cordinjury (SCI), demonstrate that treat...ty around the injury. Mostimportantly, in a severe model of SCI where animals are paraplegicpost- injury, they observed a statistically significant(p "I am ...Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose
... efficacyof the device on human subjects using its model drug compound. Thedose escalation trial showed sta..., medium and highconcentrations, for 16 hours, the model drug permeated eachsubject's skin on multiple occasions, resulting in clear anddistinct peaks and tr......osis and with preclinical results in the DMD mouse model thatwere recently published in Nature. We are eager to extend testingof this concept into other nonsense-mediated geneticdisorders." About Duchenne Muscular Dystrophy Duchenne muscular dystrophy (DMD) is a progressive muscledisorder that causes the......mmation, axonalloss and demyelination in an animal model of MS. "COPAXONE(R) is one of the most frequently used RRMS therapiesdue to its proven efficacy and safety and unique presumed mechanismof action," said Metz. "In previous studies, COPAXONE(R) has shownefficacy and safety both in combination with in...Data to be presented at AAN Meeting -Study results of drug candidate for MS
...he third study, conducted in an established animal model ofMS [experimental autoimmune encephalomyelitis (E...mmune encephalomyelitis (EAE) inDA rats, an animal model of multiple sclerosis. Conclusion/Relevance: These studies suggest that the mechanismof action of F......mmation, axonalloss and demyelination in an animal model of MS. "COPAXONE(r) is one of the most frequently used RRMS therapiesdue to its proven efficacy and safety and unique presumed mechanismof action," said Metz. "In previous studies, COPAXONE(r) has shownefficacy and safety both in combination with in...Xanthus Presents Novel Approach for Autoimmune Disease Reversal with Symadex
... pathological signs of chronicdisease in an animal model for multiple sclerosis. The presentationwas made b...cademy of Neurology Meeting in Boston, MA. Using a model of experimental autoimmune encephalomyelitis (EAE)that is designed to represent multiple sclerosis, ...... which represent the mostrelevant influenza animal model for humans, were then challengedwith live H5N1 vir...ferret has proved to be the most predictive rodent model forsuccess in human clinical trials for influenza. "Novavax's proprietary vaccine may be the very f...Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
...erers.The study incorporated an early intervention model in whichpatients were instructed to treat while migraine pain was mild andwithin one hour of onset. Patients were randomized to one of fivegroups and instructed to treat four migraine attacks. Most patients(80 percent) treated three of four attacks w...